The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InThe scope of securities litigation against US-listed corporations has expanded to include major healthcare and technology firms, with new class action lawsuits filed against Boston Scientific Corporation (BSX) and Snowflake, Inc. (SNOW). Boston Scientific faces allegations of securities fraud affecting investors who purchased shares between July 2025 and February 2026, while Snowflake’s case covers the period from June 2023 to February 2024. These firms join a growing list of companies, including Stellantis, Lucid Group, and Gartner, accused of issuing misleading statements. The Portnoy Law Firm has issued formal alerts to affected investors regarding upcoming legal deadlines, including a lead plaintiff deadline of April 27, 2026, for Snowflake. Market analysts are closely monitoring the impact of this mounting legal pressure on corporate reputations and operational costs as investigations spread across diverse sectors. These actions seek to recover financial damages for shareholders who suffered losses due to alleged violations of federal securities laws.